FEROX STRATEGIES

Lobbying for ELI LILLY AND COMPANY · American pharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 18, 2025

Lobbying activity 1

Pharmacy

Issues related to the pharmaceutical industry. Issues related to Treating and Reducing Obesity.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.